Consultations

This website provides hospital pharmacists with information on open consultations that are being conducted by EAHP, the European Medicines Agency, the European Commission and any other entities or individuals. 

EAHP 

Patient safety is a priority for healthcare organisations worldwide. Due to the complex nature of the ICU setting, specific strategies for improving medication safety are likely to be particularly important. EAHP's SIG for the Investigation of Medication Errors in ICUs is consequently looking to identify medication error prevention strategies both in use and being planned in ICUs across Europe, in order to develop policy recommendations for medication safety improvement. Please share your feedback by the 8th of May 2022.

Access the English version of the survey
https://easy-feedback.de/SIGSurveymedicationerrors/1449652/2x88c0
Access the Estonian version of the survey
https://easy-feedback.de/SIGsurveymedicationerrors/1453544/8LHzg3
Access the French version of the survey
https://easy-feedback.de/SIGMedicationerrorsFrenchtranslation/1453156/7h...
Access the German version of the survey
https://easy-feedback.de/SIGsurveymedicationerrorsGermantranslation/1453...
Access the Italian version of the survey
https://easy-feedback.de/SIGsurveymedicationerrorsItaliantranslation/145...
Access the Slovenian version of the survey
https://easy-feedback.de/s/1453648/Bb28RA
Access the Spanish version of the survey
https://easy-feedback.de/SIGsurveymedicationerrorspanishtranslation/1453...

European Medicines Agency (EMA)

Due date Name of consultation  Scope of consultation
06/08/2022 ICH guideline E11A on pediatric extrapolation This guideline provides recommendations for harmonised approaches for paediatric extrapolation to support the development and authorisation of paediatric medicines. It provides a framework for using extrapolation as a tool to support paediatric drug development that encompasses an iterative process for understanding the existing information available, the gaps in information needed to inform development and ways to generate additional information when needed.
08/09/2022 [DRAFT] Guidance document on how to approach the protection of personal data and commercially confidential information in documents uploaded and published in the Clinical Trial Information System (CTIS)  This guidance document focuses on the following areas:
  • Description of the CTIS structure and components including a description of the functionalities and publication rules for clinical trials information submitted to the CTIS
  • The protection of personal data as part of the clinical trial information submitted to CTIS
  • The protection of commercially confidential information (CCI) as part of the clinical trial information submitted to CTIS
  • The protection of personal data and CCI in inspection reports 

EDQM

No open consultation at the moment.

Others

Due date Name of consultation  Scope of consultation
None indicated

Survey: Outpatient Parenteral Antimicrobial Therapy (OPAT) services worldwide

 A group of Dutch hospital pharmacists is currently studying the degree of implementation of Outpatient Parenteral Antimicrobial Therapy (OPAT) worldwide. To obtain more information on this topic colleagues from around the globe are invited to provide feedback to a short survey that will only take a few minutes to complete.
Last update: 19 April 2022